Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin)

Sadikova N.G; Najmutdinova D. K; Urunbayeva D. A; Alimova S. E; Tillaboyev Sh.Sh

Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin)

Authors

Sadikova N.G Tashkent medical academy, Tashkent Uzbekistan
Najmutdinova D. K Tashkent medical academy, Tashkent Uzbekistan.
Urunbayeva D. A Tashkent medical academy, Tashkent Uzbekistan.
Alimova S. E Tashkent medical academy, Tashkent Uzbekistan.
Tillaboyev Sh.Sh Tashkent medical academy, Tashkent Uzbekistan

Keywords:

SGLT-2ingibitors, Diabetes Mellitus

Abstract

Study of the effect of SGLT-2ingibitors on kidney function in Diabetes Mellitus Type 2 patients

Downloads

Published

2023-11-06

How to Cite

Sadikova N.G, Najmutdinova D. K, Urunbayeva D. A, Alimova S. E, & Tillaboyev Sh.Sh. (2023). Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). Eurasian Journal of Research, Development and Innovation, 26, 1–4. Retrieved from https://geniusjournals.org/index.php/ejrdi/article/view/5178